pancreatic ductal adenocarcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who have been or will be treated for pancreatic cancer at our hospital 2)Age 20 years or older 3) Patients who are able to collect new peripheral blood (10ml) 4) Patients who have sufficient judgment to understand the contents of the study and have given written consent.
Exclusion criteria
Exclusion criteria: None in particular
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of miRs associated with early recurrence | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between candidate miRs and prognosis | — |
Countries
Japan
Contacts
Sapporo Medical University Department of Surgery, Surgical Oncology and Science